119th Congress · introduced in the House · Jan 15, 2026
Genomic Answers for Children’s Health Act of 2026
Official title from Congress.gov
Latest action (Jan 15, 2026): Referred to the House Committee on Energy and Commerce.
View on Congress.govPolicy area: Health
No official summary has been published for this bill.
Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Introduced in House
Actions from Congress.gov, newest first.
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 23, 2026.
54 citations; showing the 25 most recently posted.
ILLUMINA, INC. · lobbying firm or registrant: ILLUMINA, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Medicare/Medicaid
$240,000
Spent on own lobbying
H.R. 7118: Genomic Answers for Childrens Health Act of 2026; all provisions
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ILLUMINA, INC. · lobbying firm or registrant: AVENUE SOLUTIONS
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$60,000
Paid to lobbying firm
Issues related to genomic sequencing; H.R. 7118, Genomic Answers for Childrens Health Act of 2026
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ASTRAZENECA PHARMACEUTICALS LP · lobbying firm or registrant: ASTRAZENECA PHARMACEUTICALS LP
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Medicare/Medicaid
$810,000
Spent on own lobbying
HR 7118 Genomic Answers for Children's Health Act HR 9599 The SECURE 340B Act Policies related to the use of international reference pricing in Medicare/Medicaid 340B…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
GENEDX, LLC · lobbying firm or registrant: RED+BLUE STRATEGIES
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Medicare/Medicaid
$80,000
Paid to lobbying firm
…lace coverage. Issues related to the FY27 Labor-HHS appropriations process - highlighting Genetic Testing Guidance for State Medicaid Programs report language. H.R. 7118 - Genomic Answers for Children's Health Act of 2026 - support for clarifying access to genomic sequencing for children enrolled in Medicaid who have a suspecte…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BEREN THERAPEUTICS · lobbying firm or registrant: GRIDIRON PUBLIC AFFAIRS, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
Amount not reported
Issues related to patient access to innovative therapies,H.R. 4709 - Newborn Screening Saves Lives Reauthorization, H.R. 7118 - Genomic Answers for Children's Health
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. View filing
AMERICAN COLLEGE OF MEDICAL GENETICS · lobbying firm or registrant: KING & SPALDING LLP
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 19, 2026 · issue area: Health Issues
$20,000
Paid to lobbying firm
…genetics and genetic testing, including H.R. 4709, the Newborn Screening Saves Lives Reauthorization Act; H.R. 6208, Access to Genetic Counselor Services Act; H.R. 7118, Genomic Answers for Childrens Health Act; H.R. 2471, Right Dose Right Now Act; FY2027 Labor-HHS-Education Appropriations, and H.R. 10571, the Surge to Save Ne…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NEMOURS FOUNDATION - A FLORIDA NOT-FOR-PROFIT CORPORATION · lobbying firm or registrant: THE NEMOURS FOUNDATION - A FLORIDA NOT-FOR-PROFIT CORPORATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 19, 2026 · issue area: Medicare/Medicaid
$130,000
Spent on own lobbying
Issues related to Medicaid H.R. 7118, Genomic Answers for Childrens Health Act of 2026 Issues related to Hospital at Home
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
EXACT SCIENCES CORPORATION · lobbying firm or registrant: ALPINE GROUP PARTNERS, LLC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 17, 2026 · issue area: Medicare/Medicaid
$20,000
Paid to lobbying firm
H.R.7118 Genomic Answers for Children's Health Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
EXACT SCIENCES CORPORATION · lobbying firm or registrant: ALPINE GROUP PARTNERS, LLC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 17, 2026 · issue area: Health Issues
$20,000
Paid to lobbying firm
H.R.7118 Genomic Answers for Children's Health Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
RARE FOUNDATION (FORMERLY KNOWN AS EVERYLIFE FOUNDATION FOR RARE DISEASES) · lobbying firm or registrant: RARE FOUNDATION (FORMERLY KNOWN AS EVERYLIFE FOUNDATION FOR RARE DISEASES)
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 16, 2026 · issue area: Health Issues
$60,000
Spent on own lobbying
…2 - Scientific EXPERT Act of 2025; H.R. 4709 - Newborn Screening Saves Lives Reauthorization Act of 2025; FY 2027 Appropriations; FDA user fee reauthorization; H.R. 7118 - Genomic Answers for Children's Health Act; H.R. 5509, S. 2903 - Safe Step Act; H.R. 1414 - Cameron's Law; H.R. 10359 - Priority for Pediatric Cures Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
COLLEGE OF AMERICAN PATHOLOGISTS · lobbying firm or registrant: COLLEGE OF AMERICAN PATHOLOGISTS
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 15, 2026 · issue area: Health Issues
$203,130
Spent on own lobbying
…ortance of clinical roles of locum tenens physicians, and for other purposes H.R.7520 - Efficiency Adjustment Delay Act S.3762 - Prior Authorization Relief Act H.R.7118 - Genomic Answers for Childrens Health Act H.R. 1, the One Big, Beautiful Bill Act Improving seniors' timely access to care act (S. 1816 / H.R. 3514) Genomic D…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SOLENO THERAPEUTICS, INC. · lobbying firm or registrant: SOLENO THERAPEUTICS, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Sep 29, 2026 · issue area: Health Issues
$70,000
Spent on own lobbying
H.R.7118, Genomic Answers for Childrens Health Act; H.R.1414, Camerons Law; H.R.1492/S.832, EPIC Act; Most Favored Nation, orphan drug exemption
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SOLENO THERAPEUTICS, INC. · lobbying firm or registrant: SOLENO THERAPEUTICS, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Sep 29, 2026 · issue area: Medicare/Medicaid
$70,000
Spent on own lobbying
H.R.7118, Genomic Answers for Childrens Health Act; H.R.1414, Camerons Law; H.R.1492/S.832, EPIC Act; Most Favored Nation, orphan drug exemption
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SOLENO THERAPEUTICS, INC. · lobbying firm or registrant: SOLENO THERAPEUTICS, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Sep 29, 2026 · issue area: Insurance
$70,000
Spent on own lobbying
H.R.7118, Genomic Answers for Childrens Health Act; H.R.1414, Camerons Law; H.R.1492/S.832, EPIC Act; Most Favored Nation, orphan drug exemption
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SOLENO THERAPEUTICS, INC. · lobbying firm or registrant: SOLENO THERAPEUTICS, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Sep 29, 2026 · issue area: Economics/Economic Development
$70,000
Spent on own lobbying
H.R.7118, Genomic Answers for Childrens Health Act; H.R.1414, Camerons Law; H.R.1492/S.832, EPIC Act; Most Favored Nation, orphan drug exemption
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SOLENO THERAPEUTICS, INC. · lobbying firm or registrant: SOLENO THERAPEUTICS, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Sep 29, 2026 · issue area: Pharmacy
$70,000
Spent on own lobbying
H.R.7118, Genomic Answers for Childrens Health Act; H.R.1414, Camerons Law; H.R.1492/S.832, EPIC Act; Most Favored Nation, orphan drug exemption
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SOLENO THERAPEUTICS, INC. · lobbying firm or registrant: SOLENO THERAPEUTICS, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Sep 29, 2026 · issue area: Trade (domestic/foreign)
$70,000
Spent on own lobbying
H.R.7118, Genomic Answers for Childrens Health Act; H.R.1414, Camerons Law; H.R.1492/S.832, EPIC Act; Most Favored Nation, orphan drug exemption
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SOLENO THERAPEUTICS, INC. · lobbying firm or registrant: SOLENO THERAPEUTICS, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Sep 29, 2026 · issue area: Financial Institutions/Investments/Securities
$70,000
Spent on own lobbying
H.R.7118, Genomic Answers for Childrens Health Act; H.R.1414, Camerons Law; H.R.1492/S.832, EPIC Act; Most Favored Nation, orphan drug exemption
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ILLUMINA, INC. · lobbying firm or registrant: ILLUMINA, INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 21, 2026 · issue area: Medicare/Medicaid
$300,000
Spent on own lobbying
H.R. 7118: Genomic Answers for Childrens Health Act of 2026; all provisions
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN COLLEGE OF MEDICAL GENETICS · lobbying firm or registrant: KING & SPALDING LLP
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Health Issues
$20,000
Paid to lobbying firm
…genetics and genetic testing, including H.R. 4709, the Newborn Screening Saves Lives Reauthorization Act; H.R. 6208, Access to Genetic Counselor Services Act; H.R. 7118, Genomic Answers for Childrens Health Act; H.R. 2471, Right Dose Right Now Act; and FY2027 Labor-HHS-Education Appropriations.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SOLENO THERAPEUTICS, INC. · lobbying firm or registrant: SOLENO THERAPEUTICS, INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Pharmacy
$70,000
Spent on own lobbying
H.R.7118, Genomic Answers for Childrens Health Act; H.R.1414, Camerons Law; H.R.1492/S.832, EPIC Act; Most Favored Nation, orphan drug exemption
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SOLENO THERAPEUTICS, INC. · lobbying firm or registrant: SOLENO THERAPEUTICS, INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Trade (domestic/foreign)
$70,000
Spent on own lobbying
H.R.7118, Genomic Answers for Childrens Health Act; H.R.1414, Camerons Law; H.R.1492/S.832, EPIC Act; Most Favored Nation, orphan drug exemption
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SOLENO THERAPEUTICS, INC. · lobbying firm or registrant: SOLENO THERAPEUTICS, INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Financial Institutions/Investments/Securities
$70,000
Spent on own lobbying
H.R.7118, Genomic Answers for Childrens Health Act; H.R.1414, Camerons Law; H.R.1492/S.832, EPIC Act; Most Favored Nation, orphan drug exemption
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SOLENO THERAPEUTICS, INC. · lobbying firm or registrant: SOLENO THERAPEUTICS, INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Health Issues
$70,000
Spent on own lobbying
H.R.7118, Genomic Answers for Childrens Health Act; H.R.1414, Camerons Law; H.R.1492/S.832, EPIC Act; Most Favored Nation, orphan drug exemption
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SOLENO THERAPEUTICS, INC. · lobbying firm or registrant: SOLENO THERAPEUTICS, INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Medicare/Medicaid
$70,000
Spent on own lobbying
H.R.7118, Genomic Answers for Childrens Health Act; H.R.1414, Camerons Law; H.R.1492/S.832, EPIC Act; Most Favored Nation, orphan drug exemption
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing